https://www.selleckchem.com/pr....oducts/Gefitinib.htm
The aim of the present study was to determine the incidence of unexpected gynaecological malignancies in patients undergoing hysterectomy for benign indications and to evaluate their clinical characteristics. Data from 6448 cases who had undergone hysterectomy for benign indications between the dates of 01.01.2008-01.01.2018 were recorded retrospectively from the database of the institution. The mean age of the cases with malignancy was 59.2 ± 9.66 (45-8 and 76,31% were (29/38) postmenopausal. The mean gravidity was 3.94 ± 1.73 and
Like
Comment
Share
